REFERENCES
- Brudney, D. 2009. Choosing for another: Beyond autonomy and best interests. Hastings Center Report 39 (2):31–37. doi:10.1353/hcr.0.0113.
- Dickert, N. W., N. Eyal, S. Goldkind, et al. 2017. Reframing consent for clinical research: A function-based approach. American Journal of Bioethics 17 (12):3–11.
- Love, R. R., and N. C. Fost. 1997. Ethical and regulatory challenges in a randomized control trial of adjuvant treatment for breast cancer in Vietnam. Journal of Investigative Medicine 45 (8):423–31.
- Miller, F. G., and A. Wertheimer. 2011. The fair transaction model of informed consent: An alternative to autonomous authorization. Kennedy Institute of Ethics Journal 21 (3):201–18. doi:10.1353/ken.2011.0013.
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. Ethical principles and guidelines for the protection of human subjects of research. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html.
- U.S. Department of Health and Human Services. 1991a. Code of federal regulations, 45 CFR 46 Subpart A. Available at: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/common-rule/index.html
- U.S. Department of Health and Human Services. 1991b. Code of federal regulations, 45 CFR 46 Subpart D.46.406. Available at: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html#subpartd
- Wertheimer, A. 2015. The social value requirement reconsidered. Bioethics 29 (5):301–8. doi:10.1111/bioe.12128.